These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 32915082)
1. Effects of Alternative Splicing Events on Acute Myeloid Leukemia. Chen SL; Dai YJ; Hu F; Wang Y; Li H; Liang Y DNA Cell Biol; 2020 Nov; 39(11):2040-2051. PubMed ID: 32915082 [TBL] [Abstract][Full Text] [Related]
2. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia. Jin P; Tan Y; Zhang W; Li J; Wang K Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835 [TBL] [Abstract][Full Text] [Related]
3. Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases. Xie ZC; Gao L; Chen G; Ma J; Yang LH; He RQ; Li MW; Cai KT; Li TT; Peng ZG Neoplasma; 2020 May; 67(3):623-635. PubMed ID: 32039631 [TBL] [Abstract][Full Text] [Related]
4. Identification of survival-related alternative splicing signatures in acute myeloid leukemia. Zhang B; Yang L; Wang X; Fu D Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178 [TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma. Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases. Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Characterization of the Prognosis Value of Alternative Splicing Events in Acute Myeloid Leukemia. Chen XX; Zhu JH; Li ZP; Xiao HT; Zhou H DNA Cell Biol; 2020 Jul; 39(7):1243-1255. PubMed ID: 32543226 [TBL] [Abstract][Full Text] [Related]
8. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas. Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718 [TBL] [Abstract][Full Text] [Related]
9. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma. Wan Q; Sang X; Jin L; Wang Z Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases. He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970 [TBL] [Abstract][Full Text] [Related]
11. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data. Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163 [TBL] [Abstract][Full Text] [Related]
12. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data. Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164 [TBL] [Abstract][Full Text] [Related]
13. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma. Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730 [TBL] [Abstract][Full Text] [Related]
14. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia. Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia. Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia. Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia. Zeng H; Wu H; Yan M; Tang L; Guo X; Zhao X Leuk Res; 2020 Jan; 88():106261. PubMed ID: 31739140 [TBL] [Abstract][Full Text] [Related]
18. Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia. Wang E; Lu SX; Pastore A; Chen X; Imig J; Chun-Wei Lee S; Hockemeyer K; Ghebrechristos YE; Yoshimi A; Inoue D; Ki M; Cho H; Bitner L; Kloetgen A; Lin KT; Uehara T; Owa T; Tibes R; Krainer AR; Abdel-Wahab O; Aifantis I Cancer Cell; 2019 Mar; 35(3):369-384.e7. PubMed ID: 30799057 [TBL] [Abstract][Full Text] [Related]
19. RNA-Seq analysis identifies aberrant RNA splicing of TRIP12 in acute myeloid leukemia patients at remission. Gao P; Jin Z; Cheng Y; Cao X Tumour Biol; 2014 Oct; 35(10):9585-90. PubMed ID: 24961348 [TBL] [Abstract][Full Text] [Related]
20. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia. Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]